Recombinant Human Anti-OR2T1 Soluble TCR (AA1) (C-Cys) (CAT#: VS-0622-YF4783)
Human TCR (AA1) recognizes OR2T1 peptide (FLNVLFPLL) in the context of HLA-A2. Soluble TCR is expressed with C-terminal Cys strategy (TRAV-TRAC partial-Cys, TRBV-TRBC partial-Cys). Depending the C-terminal Cys, two chains form heterodimer. Please note that the activity is not guaranteed.
Specific Inquiry
Specifications
- Host Species
- Human
- Target
- OR2T1
- Epitope
- FLNVLFPLL
- MHC
- HLA-A2
- Clone
- AA1
- Type
- Soluble TCR (C-Cys)
- TCR Expression Strategy
- C-Cys strategy: the alpha and beta chain (without transmembrane and cytosolic region) can form heterodimer based on C-terminal Cys. The soluble TCR contains variable regions and partial constant regions.
Target
- Alternative Names
- Olfactory Receptor Family 2 Subfamily T Member 1 variant FLN_F5L; FLNVLFPLL
Downloads
Download resources about recombinant antibody development and antibody engineering to boost your research.
See other products for "Clone AA1"
Customer Reviews and Q&As
There are currently no Customer reviews or questions for VS-0622-YF4783. Click the button above to contact us or submit your feedback about this product.
Popular products with customers
Application: ELISA, IP, FC, FuncS, Neut, IF, WB
Application: IP, IF, FuncS, FC, Neut, ELISA, ICC
Application: IP, IF, FuncS, FC, Neut, ELISA, IHC
Application: WB, ELISA, FuncS
Application: Depletion, FuncS
Application: ELISA, FuncS, IHC, IF, FC, ADCC
Application: ELISA, IHC, FC, IP, IF, Inhib
Application: ELISA, Inhib, FuncS
Application: Neut, ELISA, WB, SPR, IF, EM
Application: WB, IHC-Fr, IHC-P, ICC, IF
For Research Use Only. Not For Clinical Use.
Send Inquiry
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.